Stock Update: CVS Health Corporation (NYSE:CVS)

[PR Newswire] CVS Health Corporation (NYSE:CVS) is thanking its 26,000 pharmacists during October's American Pharmacists Month for their role in changing the way health care is delivered to increase access, lower costs and improve quality in the Company's retail pharmacies, mail service pharmacies and specialty pharmacies nationwide."Last month, we changed our company name to CVS Health to reflect our broader health care commitment and our expertise in driving the innovations needed to shape the future of health," said Larry Merlo, President and CEO of CVS Health.Stock PerformanceTaking a look at the company’s recent performance, CVS Health Corporation (CVS) reported second quarter earnings for fiscal 2014 on August 5^th. The company reported actual earnings per share of $1.13 against the consensus Street estimate of $1.10. This represents year over year growth of 8.12%. CVS Health posted revenue of $34.60 billion against estimates of $33.47 billion.CVS Health Corporation (CVS) is currently valued at $91.79 billion and closed the last trading session at $78.99. The stock has a 50-day moving average of $80.17 and a 200-day moving average of $77.03.

Is this a Buying Opportunity?There are currently fifteen analysts that we track that cover the stock. Of those fifteen, ten have a Buy rating, three have a hold rating and two have a Sell rating. On a consensus basis this yields a score of 2.53 and a Buy. The combined price objective of these covering analysts is $79.24, which represents a -1.03% difference to the last closing price.The most recent analyst activity consisted of Cowen and Companyupgrading their Market perform stance on the company. Cowen and Company has a price target of $92 which represents an upside of 13.5% from the last closing price. On the date of the report, the stock closed at $81.24.Another research firm weighing in recently was Zacks who reiterated their rating on the stock. On Sept 12^th Zacks reiterated their price target on the stock at $82, or a 1.2% upside to the current price. On the day of the report, CVS shares closed at $80.57.Company ProfileCVS Health Corporation (NYSE:CVS), together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The Pharmacy Services segment offers pharmacy benefit management services, such as plan design and administration, formulary management, discounted drug purchase arrangements, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management, and medical spend management services